236 related articles for article (PubMed ID: 30314448)
1. Epidemiology of hepatitis B, C and D in Malawi: systematic review.
Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA
BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448
[TBL] [Abstract][Full Text] [Related]
2. HDV Seroprevalence in HBsAg-Positive Patients in China Occurs in Hotspots and Is Not Associated with HCV Mono-Infection.
Roggenbach I; Chi X; Lempp FA; Qu B; Walter L; Wu R; Gao X; Schnitzler P; Ding Y; Urban S; Niu J
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578380
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B, C, and D virus infection in Haiti: A systematic review and meta-analysis.
Vincent JP; Nyamasege C; Wang S; Madec Y; Shimakawa Y
Front Public Health; 2022; 10():1099571. PubMed ID: 36711383
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B, C, and D Virus Infections and AFP Tumor Marker Prevalence Among the Elderly Population in Mongolia: A Nationwide Survey.
Dambadarjaa D; Mukhtar Y; Tsogzolbaatar EO; Khuyag SO; Dayan A; Oyunbileg NE; Shagdarsuren OE; Nyam G; Nakamura Y; Takahashi M; Okamoto H
J Prev Med Public Health; 2022 May; 55(3):263-272. PubMed ID: 35678000
[TBL] [Abstract][Full Text] [Related]
5. Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort.
d'Arminio Monforte A; Tavelli A; Salpini R; Piermatteo L; D'Anna S; Carrara S; Malagnino V; Mazzotta V; Brancaccio G; Marchetti GC; Rosselli Del Turco E; Rossotti R; Mussini C; Antinori A; Lo Caputo S; Ceccherini Silberstein F; Gaeta GB; Svicher V; Puoti M;
Liver Int; 2024 Feb; 44(2):603-613. PubMed ID: 38100128
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis B, C, and D and associated factors in the semi-isolated Yanomami Amazonian indigenous community.
Vasconcelos MPA; Sánchez-Arcila JC; Peres L; de Sousa PSF; Castro-Alves J; Albuquerque HG; Mendes-Correa MC; Maia-Herzog M; Lewis-Ximenez LL; Villar LM; Oliveira-Ferreira J
BMC Infect Dis; 2024 Jan; 24(1):15. PubMed ID: 38166687
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis.
Kenfack-Momo R; Kenmoe S; Takuissu GR; Ebogo-Belobo JT; Kengne-Ndé C; Mbaga DS; Tchatchouang S; Oyono MG; Kenfack-Zanguim J; Lontuo Fogang R; Mbongue Mikangue CA; Zeuko'o Menkem E; Ndzie Ondigui JL; Kame-Ngasse GI; Magoudjou-Pekam JN; Taya-Fokou JB; Bowo-Ngandji A; Nkie Esemu S; Kamdem Thiomo D; Moundipa Fewou P; Ndip L; Njouom R
PLoS One; 2022; 17(5):e0269250. PubMed ID: 35639675
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B, C, and delta in the general population in Mayotte: hepatitis B as a major public health concern.
Brouard C; Parenton F; Youssouf H; Chevaliez S; Gordien E; Jean M; Bruyand M; Vaux S; Lot F; Ruello M;
BMC Infect Dis; 2022 Aug; 22(1):716. PubMed ID: 36038821
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence and molecular genetic characteristics of parenteral hepatitis B, C and D viruses in HIV positive persons in the Novosibirsk region].
Kartashov MY; Svirin KA; Krivosheina EI; Chub EV; Ternovoi VA; Kochneva GV
Vopr Virusol; 2022 Nov; 67(5):423-438. PubMed ID: 36515288
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis delta infection among persons living with HIV in Europe.
Béguelin C; Atkinson A; Boyd A; Falconer K; Kirkby N; Suter-Riniker F; Günthard HF; Rockstroh JK; Mocroft A; Rauch A; Peters L; Wandeler G;
Liver Int; 2023 Apr; 43(4):819-828. PubMed ID: 36625770
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study.
Chasela CS; Wall P; Drobeniuc J; King CC; Teshale E; Hosseinipour MC; Ellington SR; Codd M; Jamieson DJ; Knight RJ; Fitzpatrick P; Kourtis AP; Hoffman IF; Kayira D; Mumba N; Kamwendo DD; Martinson F; Powderly W; van der Horst C; Kamili S;
J Clin Virol; 2012 Aug; 54(4):318-20. PubMed ID: 22658797
[TBL] [Abstract][Full Text] [Related]
12. The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis.
Daw MA; Daw AM; Sifennasr NEM; Draha AM; Daw AM; Daw AM; Ahmed MO; Mokhtar ES; El-Bouzedi A; Daw IM
ScientificWorldJournal; 2018; 2018():9312650. PubMed ID: 30356409
[TBL] [Abstract][Full Text] [Related]
13. A clinical and molecular epidemiological survey of hepatitis C in Blantyre, Malawi, suggests a historic mechanism of transmission.
Stockdale AJ; Kreuels B; Shawa IT; Meiring JE; Thindwa D; Silungwe NM; Chetcuti K; Joekes E; Mbewe M; Mbale B; Patel P; Kachala R; Patel PD; Malewa J; Finch P; Davis C; Shah R; Tong L; da Silva Filipe A; Thomson EC; Geretti AM; Gordon MA
J Viral Hepat; 2022 Apr; 29(4):252-262. PubMed ID: 35075742
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of Hepatitis B, C and D in Germany: A scoping review.
Steffen G; Sperle I; Leendertz SA; Sarma N; Beermann S; Thamm R; Bremer V; Zimmermann R; Dudareva S
PLoS One; 2020; 15(3):e0229166. PubMed ID: 32150561
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study.
Tazinkeng NN; Teuwafeu DG; Asombang AW; Agbor VN; Bloom SM; Nkhoma AN; Mohareb AM; Luma HN
Liver Int; 2022 Nov; 42(11):2396-2402. PubMed ID: 35946051
[TBL] [Abstract][Full Text] [Related]
16. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
[TBL] [Abstract][Full Text] [Related]
17. Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.
Rupasinghe D; Choi JY; Kumarasamy N; Pujari S; Sun LP; Merati TP; Lee MP; Kinh NV; Kiertiburanakul S; Do CD; Avihingsanon A; Ross J; Jiamsakul A;
HIV Med; 2022 Oct; 23(9):959-968. PubMed ID: 35218151
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings.
Kamga Wouambo R; Panka Tchinda G; Kagoue Simeni LA; Djouela Djoulako PD; Yateu Wouambo CI; Tamko Mella GF; Tchoumi Leuwat EP; Bello D; Fokam J
BMC Infect Dis; 2023 Dec; 23(1):875. PubMed ID: 38093205
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Hepatitis B, C and D in Vietnam: A systematic review and meta-analysis.
Flower B; Du Hong D; Vu Thi Kim H; Pham Minh K; Geskus RB; Day J; Cooke GS
Lancet Reg Health West Pac; 2022 Jul; 24():100468. PubMed ID: 35573318
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022.
Kandeel A; Fahim M; Abukamar S; BahaaEldin H; Abuelsood H; Samy S; Deghedy O; Sheta A; Naguib A; El Guindy N; Youssef A; Kamel R; Afifi S; El-Kassas M; Abdelghaffar K
Liver Int; 2024 Apr; 44(4):955-965. PubMed ID: 38291807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
